Setterwalls advised Promore Pharma AB on the deal. Promore Pharma AB completed its rights issue of approximately SEK 48.6 million. Promore Pharma is a biopharmaceutical company...
Setterwalls advised Promore Pharma AB on the deal. Promore Pharma AB completed its rights issue of approximately SEK 48.6 million. Promore Pharma is a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.